UK markets close in 4 hours

Atossa Therapeutics, Inc. (ATOS)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.2000-0.0600 (-4.76%)
At close: 04:00PM EST
1.1700 -0.03 (-2.50%)
Pre-market: 06:54AM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 159.55M
Enterprise value 19.51M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.13
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.98

Trading information

Stock price history

Beta (5Y monthly) 1.97
52-week change 3-45.70%
S&P500 52-week change 316.48%
52-week high 39.8000
52-week low 31.1300
50-day moving average 31.8184
200-day moving average 33.1720

Share statistics

Avg vol (3-month) 32.98M
Avg vol (10-day) 32.26M
Shares outstanding 5126.62M
Implied shares outstanding 6N/A
Float 8126.6M
% held by insiders 10.04%
% held by institutions 125.05%
Shares short (13 Jan 2022) 417.16M
Short ratio (13 Jan 2022) 46.07
Short % of float (13 Jan 2022) 413.56%
Short % of shares outstanding (13 Jan 2022) 413.55%
Shares short (prior month 14 Dec 2021) 417.98M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 319 Apr 2018
Ex-dividend date 4N/A
Last split factor 21:12
Last split date 319 Apr 2018

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sept 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-16.12%
Return on equity (ttm)-30.76%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -19.89M
Net income avi to common (ttm)-27.76M
Diluted EPS (ttm)-0.3100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)140.04M
Total cash per share (mrq)1.11
Total debt (mrq)1.22k
Total debt/equity (mrq)0.00
Current ratio (mrq)85.32
Book value per share (mrq)1.11

Cash flow statement

Operating cash flow (ttm)-16.24M
Levered free cash flow (ttm)-8.74M